Digital capabilities, crossroads to recast the science business

Digital capabilities are today redefining the scientific, operational and commercial side of Biopharma business.
Digital science empowers advanced pharma research on focusing new targets, speed up screening and meet clinicals milestones.
Patient-centricity becomes finally achievable, with a ‘beyond the pill’ transactional approach, resulting in omnichannel patient care, patient’s journey health smart apps and personalized medicine.

As the Biopharma industry exploits digital opportunities in R&D and marketing sides, responsive supply chain ecosystems are required to come together synchronously, humans, machines, and resources as a cyber-physical system, driving all stages of the operations value chain: plan, source, make, and deliver.